Comparative mortality risk of anemia management practices in incident hemodialysis patients
Context Controversy exists about optimal management of anemia in end-stage renal
disease. Objective To compare the mortality risk of different dialysis center–level patterns of
anemia management. Design, Setting, and Patients Using data from Medicare's end-stage
renal disease program (1999-2007), we characterized each US dialysis center's annual
anemia management practice by estimating its typical use of erythropoiesis-stimulating
agents (ESAs) and intravenous iron in hemodialysis patients within 4 hematocrit categories …
disease. Objective To compare the mortality risk of different dialysis center–level patterns of
anemia management. Design, Setting, and Patients Using data from Medicare's end-stage
renal disease program (1999-2007), we characterized each US dialysis center's annual
anemia management practice by estimating its typical use of erythropoiesis-stimulating
agents (ESAs) and intravenous iron in hemodialysis patients within 4 hematocrit categories …
